These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35485888)

  • 1. Investigation and Optimization of Hydrogel Microneedles for Transdermal Delivery of Caffeine.
    Chandran R; Mohd Tohit ER; Stanslas J; Salim N; Tuan Mahmood TM
    Tissue Eng Part C Methods; 2022 Oct; 28(10):545-556. PubMed ID: 35485888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Transdermal Delivery of Acyclovir via Hydrogel Microneedle Arrays.
    Al-Badry AS; Al-Mayahy MH; Scurr DJ
    J Pharm Sci; 2023 Apr; 112(4):1011-1019. PubMed ID: 36384194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
    Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
    J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-mediated fabrication of nanocomposite hydrogel microneedles for tunable mechanical strength and controllable transdermal efficiency.
    Chi Y; Zheng Y; Pan X; Huang Y; Kang Y; Zhong W; Xu K
    Acta Biomater; 2024 Jan; 174():127-140. PubMed ID: 38042262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
    Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
    Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogel Microneedles with Programmed Mesophase Transitions for Controlled Drug Delivery.
    Dawud H; Edelstein-Pardo N; Mulamukkil K; Amir RJ; Abu Ammar A
    ACS Appl Bio Mater; 2024 Mar; 7(3):1682-1693. PubMed ID: 38335540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin.
    Sabri AHB; Anjani QK; Utomo E; Ripolin A; Donnelly RF
    Int J Pharm; 2022 Apr; 617():121593. PubMed ID: 35182702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
    Kim M; Jung B; Park JH
    Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microwave-Assisted Preparation of Hydrogel-Forming Microneedle Arrays for Transdermal Drug Delivery Applications.
    Larrañeta E; Lutton RE; Brady AJ; Vicente-Pérez EM; Woolfson AD; Thakur RR; Donnelly RF
    Macromol Mater Eng; 2015 Jun; 300(6):586-595. PubMed ID: 27346983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.
    Migdadi EM; Courtenay AJ; Tekko IA; McCrudden MTC; Kearney MC; McAlister E; McCarthy HO; Donnelly RF
    J Control Release; 2018 Sep; 285():142-151. PubMed ID: 29990526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
    Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
    Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery.
    Donnelly RF; McCrudden MT; Zaid Alkilani A; Larrañeta E; McAlister E; Courtenay AJ; Kearney MC; Singh TR; McCarthy HO; Kett VL; Caffarel-Salvador E; Al-Zahrani S; Woolfson AD
    PLoS One; 2014; 9(10):e111547. PubMed ID: 25360806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
    Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
    Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF; Garland MJ; Alkilani AZ
    Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
    Gao X; Brogden NK
    J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
    Han T; Das DB
    J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
    Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
    Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.